tiprankstipranks
Advertisement
Advertisement
Passage Bio downgraded to Neutral from Buy at Guggenheim
PremiumThe FlyPassage Bio downgraded to Neutral from Buy at Guggenheim
1M ago
Passage Bio Ends Key Collaborations and Office Lease
Premium
Company Announcements
Passage Bio Ends Key Collaborations and Office Lease
2M ago
Passage Bio Shareholders Approve Directors and Executive Pay
Premium
Company Announcements
Passage Bio Shareholders Approve Directors and Executive Pay
2M ago
Intel upgraded, Reddit initiated: Wall Street’s top analyst calls
PremiumThe FlyIntel upgraded, Reddit initiated: Wall Street’s top analyst calls
3M ago
Passage Bio price target lowered to $15 from $30 at Oppenheimer
Premium
The Fly
Passage Bio price target lowered to $15 from $30 at Oppenheimer
3M ago
Buy Rating Reaffirmed on Encouraging upliFT-D Biomarker Data and Solid Cash Runway Supporting Expanded FTD-GRN Trial
Premium
Ratings
Buy Rating Reaffirmed on Encouraging upliFT-D Biomarker Data and Solid Cash Runway Supporting Expanded FTD-GRN Trial
3M ago
Passage Bio Announces PBFT02 Data and Strategic Review
PremiumCompany AnnouncementsPassage Bio Announces PBFT02 Data and Strategic Review
3M ago
Passage Bio reports updated interim data from upliFT-D trial
Premium
The Fly
Passage Bio reports updated interim data from upliFT-D trial
3M ago
Passage Bio initiated with an Outperform at Oppenheimer
Premium
The Fly
Passage Bio initiated with an Outperform at Oppenheimer
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100